Dr. Michelle M. Zhang is an expert in the field of Hematology. He attended Beijing Medical University. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Michelle M. Zhang is a published MD. He has 2 publications published. The most current publication "A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed lymphoma." Dr. Michelle M. Zhang is registered with Medicare.
NPI NUMBER | 1366553513 | |
NPPES Provider LastName | ZHANG | |
NPPES Provider FirstName | MICHELLE | |
NPPES Provider ZIPCode | 980555738 | |
NPPES Provider State | WA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 996.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 104.0 | |
Percent Opioid Claims | 10.44 |
National Provider Identifier [NPI] | 1366553513 |
Last Name Of The Provider | ZHANG |
First Name Of The Provider | MICHELLE |
View All |
![]() |
Dr. Keith W. Leung, MD
![]() |
![]() |
Dr. Richard G. Ingber, MD
![]() |
![]() |
Dr. Jonathan C. Britell, MD
![]() ![]() |
![]() |
Dr. John A. Hersman, MD
![]() ![]() |
![]() |
Dr. Ying Y. Cui, MD
![]() |